Cargando…

Initial Experience after Transition to Immune Checkpoint Inhibitors in Patients with Non-small Cell Lung Cancer Treated in a Rural Healthcare Region

Objective The aim of this study was to investigate the patterns of palliative care, terminal care, and hospital deaths in deceased patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICI). Methods This study involves a retrospective analysis of a group of 32 p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nieder, Carsten, Reigstad, Anne, Carlsen, Espen A, Flatøy, Liv, Tollåli, Terje
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081957/ https://www.ncbi.nlm.nih.gov/pubmed/32211263 http://dx.doi.org/10.7759/cureus.7030

Ejemplares similares

Palliative Thoracic Radiotherapy for Lung Cancer: What Is the Impact of Total Radiation Dose on Survival?
por: Nieder, Carsten, et al.
Publicado: (2017)

Oligometastatic Non-Small Cell Lung Cancer: A Significant Entity outside of Specialized Cancer Centers?
por: Nieder, Carsten, et al.
Publicado: (2014)

Nontargeted Effect after Radiotherapy in a Patient with Non-Small Cell Lung Cancer and Bullous Pemphigoid
por: Nieder, Carsten, et al.
Publicado: (2015)

PET-CT in the sub-arctic region of Norway 2010–2013. At the edge of what is possible?
por: Norum, Jan, et al.
Publicado: (2015)

How we treat octogenarians with brain metastases
por: Nieder, Carsten, et al.
Publicado: (2023)

Frequency and Prognostic Impact of Consistently Low Edmonton Symptom Assessment System Score in the Patients Treated with Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2018)

LabBM Score and Extracranial Score As New Tools for Predicting Survival in Patients with Brain Metastases Treated with Focal Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2020)

Presence of Brain Metastases at Initial Diagnosis of Cancer: Patient Characteristics and Outcome
por: Nieder, Carsten, et al.
Publicado: (2019)

Insomnia in patients treated with checkpoint inhibitors for cancer: A meta-analysis
por: Kiss, Igor, et al.
Publicado: (2022)

Exceptional Responses to Standard Therapy in a Patient with Metastatic HER2-Positive Breast Cancer
por: Nieder, Carsten, et al.
Publicado: (2017)

Outcomes of beta blocker use in advanced hepatocellular carcinoma treated with immune checkpoint inhibitors
por: Wu, Y. Linda, et al.
Publicado: (2023)

Combined Radio- and Chemotherapy for Non-Small Cell Lung Cancer: Systematic Review of Landmark Studies Based on Acquired Citations
por: Nieder, Carsten, et al.
Publicado: (2013)

Operative management of immune checkpoint colitis following in-transit melanoma: Case report
por: Childers, Betzaira G., et al.
Publicado: (2023)

PET/CT radiomics for prediction of hyperprogression in metastatic melanoma patients treated with immune checkpoint inhibitors
por: Gabryś, H. S., et al.
Publicado: (2022)

Personalized treatment of brain metastases: Evolving survival prediction models may benefit from evaluation of serum tumor markers (narrative review)
por: Nieder, Carsten, et al.
Publicado: (2022)

Personalized radiotherapy of brain metastases: survival prediction by means of dichotomized or differentiated blood test results?
por: Nieder, Carsten, et al.
Publicado: (2023)

A Case of Five-Year Survival After Combined-Modality Treatment for Non-Small Cell Lung Cancer With Intraspinal Metastasis
por: Nieder, Carsten, et al.
Publicado: (2022)

Early High-Grade Thoracic Toxicity After Palliative Radiotherapy for Non-Small Cell Lung Cancer
por: Nieder, Carsten, et al.
Publicado: (2021)

Patterns of Failure in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immune Checkpoint Inhibitors
por: Chai, Rong, et al.
Publicado: (2021)

Association of Lymphocyte-to-Monocyte Ratio With Survival in Advanced Gastric Cancer Patients Treated With Immune Checkpoint Inhibitor
por: Chen, Yang, et al.
Publicado: (2021)

Levels of Anxiety and Depression Before Palliative Reirradiation Are Comparable to Those Before First Palliative Radiotherapy
por: Nieder, Carsten, et al.
Publicado: (2018)

Telomere Shortening in Peripheral Leukocytes Is Associated With Poor Survival in Cancer Patients Treated With Immune Checkpoint Inhibitor Therapy
por: Rolles, Benjamin, et al.
Publicado: (2021)

Hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitor therapy, fact or myth?
por: Britt, Alec S., et al.
Publicado: (2022)

Obesity, Sarcopenia, and Outcomes in Non-Small Cell Lung Cancer Patients Treated With Immune Checkpoint Inhibitors and Tyrosine Kinase Inhibitors
por: Khaddour, Karam, et al.
Publicado: (2020)

The transition between work, sickness absence and pension in a cohort of Danish colorectal cancer survivors
por: Carlsen, Kathrine, et al.
Publicado: (2013)

Biomarkers for Immune Checkpoint Inhibitors in Melanoma
por: Kitano, Shigehisa, et al.
Publicado: (2018)

Immune Checkpoint Inhibitors in the Treatment of HCC
por: Donisi, Clelia, et al.
Publicado: (2021)

Incidence of Skin and Respiratory Immune-Related Adverse Events Correlates With Specific Tumor Types in Patients Treated With Checkpoint Inhibitors
por: Rose, Lynn M., et al.
Publicado: (2021)

DNA Damage Repair Gene Mutations Are Indicative of a Favorable Prognosis in Colorectal Cancer Treated With Immune Checkpoint Inhibitors
por: Song, Yipeng, et al.
Publicado: (2021)

Risk of Cardiac Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-Analysis
por: Hu, Jiexuan, et al.
Publicado: (2021)

Is there a role for physical activity when treating patients with cancer with immune checkpoint inhibitors? Protocol for a scoping review
por: Chen, Miaoqi, et al.
Publicado: (2021)

Prognostic Impact of Sarcopenia on Clinical Outcomes in Malignancies Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis
por: Li, Shuluan, et al.
Publicado: (2021)

Prognostic role of IL-8 in cancer patients treated with immune checkpoint inhibitors: a system review and meta-analysis
por: Zou, Dan, et al.
Publicado: (2023)

Biopsy-proven acute tubulointerstitial nephritis in patients treated with immune checkpoint inhibitors: a pooled analysis of case reports
por: Esposito, Pasquale, et al.
Publicado: (2023)

Second Re-irradiation: Clinical Examples of Worthwhile Treatment
por: Nieder, Carsten, et al.
Publicado: (2018)

Second Re-irradiation of Brain Metastases: A Review of Studies Involving Stereotactic Radiosurgery
por: Nieder, Carsten, et al.
Publicado: (2018)

Late Brain Oligometastases Diagnosed at Least 36 Months after Cancer Detection are Associated with Favorable Survival Outcome
por: Nieder, Carsten, et al.
Publicado: (2020)

Dual Use of the METSSS Model Predicting Survival After Palliative Radiotherapy: An Exploratory Analysis
por: Nieder, Carsten, et al.
Publicado: (2022)

"Fighting the system": Families caring for ventilator-dependent children and adults with complex health care needs at home
por: Dybwik, Knut, et al.
Publicado: (2011)

Experiences of cancer immunotherapy with immune checkpoint inhibitors (ExCIm)—insights of people affected by cancer and healthcare professionals: a qualitative study protocol
por: Jennings, Stephen, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_38dq2n7mbb9a039ffnsllv85m5